Skip to main content

Golimumab vaysin: Ɔltin we yu nid fɔ no

Golimumab vaysin: Ɔltin we yu nid fɔ no
Yu gɛt siriɔs sik lɛk at at sik ɔr ɔlsa kɔlayt? Dɔn yu no aw i kin ambɔg yu ɛvride layf. Golimumab na spɛshal, mɔdan mɛrɛsin we dɔktɔ dɛn kin yuz fɔ kɔntrol dɛn sik ya. Lɛ wi tɔk bɔt am tide.

Wetin na Golimumab?

Fɔ tɔk am simpul wan, Golimumab na vaysin we de kɔntrol di wok we yu bɔdi in imyun sistɛm de du. Nɔmal wan, wi imyun sistɛm in wok na fɔ protɛkt wi bay we i de fɛt di jem dɛn we de mek wi gɛt sik. Bɔt sɔntɛnde, dis sistɛm kin wok pasmak ɛn mistek kin bigin fɔ atak wi yon gud sɛl dɛn. Wi kin kɔl dɛn kɔndishɔn ya ɔtoimyun kɔndishɔn. At at ɛn ɔlsa kɔlayt na tu kayn sik dɛn ya. Golimumab de wok bay we i de kɔl di ɔvaaktiv imyun sistɛm. fכ mεdikal, i de pan wan klas כf drog dεm we dεn kכl `TNF inhibitors`. Dat min se i de blok wan protin (TNF) na wi bɔdi fɔ sɔm tɛm we de mek wi fil pen ɛn swel. na wan kayn `monoclonal antibodi` bak. Dat min se na spɛshal prɔtin we dɛn mek na di lɛbɔraytri fɔ wok pan wan patikyula tin nɔmɔ we dɛn want fɔ du. Lɛk mishɔl we de nak di say we i want fɔ go.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin

Bikɔs dis na mɛrɛsin we rili pawaful, yu dɔktɔ nid fɔ gɛt kɔmplit pikchɔ bɔt yu wɛlbɔdi. So, if yu gɛt ɛni wan pan dɛn tin ya, tɛl yu dɔktɔ ɛn nɔ ayd ɛnitin .
Situeshɔn we yu nid fɔ ripɔt Wetin mek dat impɔtant?
Di sik dɛn we yu gɛt naw ɔ we yu jɔs gɛt (fiva, kɔf, kol) . Bikɔs golimumab de stɔp di imyun sistɛm, di infɛkshɔn kin bi mɔ bad.
Tuberculosis , ɔr kin gɛt tayt padi biznɛs wit pɔrsin wae gɛt TB.Dis mɛrɛsin kin mek di TB jem dɛm we de slip na di bɔdi wok bak.
Fɔ gɛt ɔ fɔ wɛl frɔm kansa . Di dɔktɔ fɔ no se dis mɛrɛsin kin gɛt fɔ du wit sɔm prɔblɛm dɛn we kin mek pɔsin gɛt kansa.
At sik dɛm lɛk at pwɛl hat . Sɔntɛnde, dis mɛrɛsin kin mek di at sik wɔs.
Shuga Di risk fɔ gɛt infɛkshɔn dɔn ɔlrɛdi bɔku bikɔs ɔf dayabitis, ɛn dis mɛrɛsin kin mek i bɔku mɔ.
Fɔ gɛt Epatitis B infɛkshɔn. Risk de fɔ mek di dormant hepatitis B vayrɔs aktiv bak bikɔs ɔf dis mɛrɛsin.
Sik dεm na di nεv sεstem (e.g. mכltipכl sklεrosis, Guillain-Barre syndrome). Sɔntɛm, dis mɛrɛsin kin afɛkt di nervɔs sistɛm.
We dɛn jɔs dɔn gɛt ɔ we dɛn dɔn sɛtul fɔ gɛt di vaysin . I nɔ fayn mɔ fɔ gɛt layf vaysin we yu de tek dis mɛrɛsin.
Tray fɔ gɛt bɛlɛ, fɔ gɛt bɛlɛ , ɔ fɔ gi pikin in bɛlɛ . Insay dɛn kayn tin ya, i rili impɔtant fɔ tɔk to yu dɔktɔ bɔt aw di mɛrɛsin go afɛkt yu.
Fɔ gɛt alɛji to ɔda mɛrɛsin, rɔba, lɛtɛks, ɛn ɔda tin dɛn. Dis impɔtant fɔ mek yu nɔ gɛt alɛji fɔ di mɛrɛsin ɔ di tin we dɛn pak am.

Aw yu kin yuz dis mɛrɛsin?

Dɛn kin gi am golimumab tu we dɛn. 1. Insay wan vein: Dɛn kin gi dis na ɔspitul ɔ klinik bay wɛlbɔdi biznɛs pɔsin tru wan salin sɔlvushɔn. 2. Ɔnda di skin: Sɔntɛnde dɛn kin mek dis vaysin so dat yu go gi am to yusɛf na os. If na so i bi, yu dɔktɔ ɔ nɔs go sho yu di rayt we fɔ du am.
Di tin we impɔtant pas ɔl: If yu na pɔsin we de gi di vaysin na os, nɔ ɛva trowe nidul ɛn sirinj we yu dɔn yuz na di dɔti. Dɛn fɔ put dɛn insay kɔntena we gɛt shap tin dɛn . If yu nɔ gɛt wan, aks yu dɔktɔ fɔ wan.
Dɔn bak, yu go gɛt wan spɛshal liflet (`MedGuide`) wit di ditel dɛn bɔt dis mɛrɛsin. Rid am gud gud wan ɛvri tɛm. I go ɛksplen bɔku tin bɔt di mɛrɛsin to yu.

Yu kin gi dis to smɔl pikin dɛn?

Yɛs, insay sɔm spɛshal kes dɛm, dɛn kin gi dis mɛrɛsin fɔ pikin dɛm we ol lɛk 2 ia. Bɔt na wan dɔktɔ we de mɛn pikin dɛn kin disayd fɔ du dat.

Wetin a fɔ du if a mis apɔntinmɛnt fɔ tek mɛrɛsin?

  • If dɛn de gi yu mɛrɛsin na ɔspitul: If yu nɔ ebul fɔ go di de we dɛn dɔn sɛtul fɔ go, kɔl di ɔspitul ɔ klinik wantɛm wantɛm ɛn mek dɛn no. Dɛn go gi yu ɔda de.
  • If yu de tek yu mɛrɛsin na os: If yu mis wan doz, tek am jɔs lɛk aw yu mɛmba. Bɔt if i dɔn lɛf smɔl fɔ lɛ yu tek di nɛks doz, skip di doz we yu mis ɛn tek di nɛks doz di tɛm we yu dɔn sɛtul. Nɔ ɛva tek dabl doz. If yu nɔ shɔ, kɔl yu dɔktɔ fɔ advays.

Wetin kin apin if yu tek bɔku mɛrɛsin?

If yu tink se yu dɔn tek bɔku mɛrɛsin, nɔ panik ɛn tek akshɔn wantɛm wantɛm.
Wantɛm wantɛm, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Us ɔda mɛrɛsin dɛn we yu nɔ fɔ yuz wit dis mɛrɛsin?

Golimumab na wan mɛrɛsin we de afɛkt di imyun sistɛm, so i kin denja fɔ tek am wit ɔda mɛrɛsin dɛn we de du di sem tin.
Nɔ tek dɛn mɛrɛsin ya wit golimumab:Abatasɛpt, Adalimumab, Anakinra, Sɛtɔlizumab, Ɛtanɛsɛpt, Infliksimab, Rilɔnasɛpt, Rituximab, Tosilizumab ɛn layf vayrɔs vaysin dɛn.
Apat frɔm dat, sɔm ɔda mɛrɛsin dɛn kin miks wit dis mɛrɛsin. Dis list nɔ kɔmplit. So, i impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, lɛk vaytamɛn dɛn, tradishɔnal mɛrɛsin dɛn, ɛn sɔpɔtmɛnt dɛn.

Wetin a fɔ tek tɛm we a de tek di mɛrɛsin?

  • Fɔ chɛk-ap ɔltɛm na di mɛrɛsin : Go na klinik dɛn di tɛm we yu dɔn sɛtul lɛk aw yu dɔktɔ tɛl yu ɛn chɛk yu kɔndishɔn.
  • TB Test: Dɛn go tɛst yu fɔ TB bifo yu bigin dis mɛrɛsin. If di tɛst sho se yu gɛt TB jem na yu bɔdi, yu go nid fɔ bigin ɛn dɔn di ful kɔs fɔ TB mɛrɛsin bifo yu bigin fɔ tek golimumab.
  • Protekshɔn frɔm infɛkshɔn : Dis mɛrɛsin de mek yu imyuniti smɔl, so yu kin sik mɔ. So, if yu gɛt sɔm sayn dɛm lɛk fiva, kol , kɔf, ɛn ɔda tin dɛm, nɔr de mɛn yusɛf ɛn tɛl yu dɔktɔ. Tray fɔ de fa frɔm pipul dɛn we sik.
  • Risk fɔ gɛt kansa : I kin rili smɔl pan di risk fɔ gɛt sɔm kayn kansa we yu de tek dis mɛrɛsin. Bifo yu panik, tɔk opin wan wit yu dɔktɔ bɔt dis ɛn ɔndastand yu yon risk.

Us sayd ɛfɛkt dɛn we a go gɛt?

Lɛk ɔl mɛrɛsin, golimumab kin mek yu gɛt sayd ɛfɛkt, pan ɔl we nɔto ɔlman kin gɛt am.
Siriɔs sayd ɛfɛkt dɛm wae yu fɔ ripɔt to yu dɔktɔ kwik kwik wan: Sid ɛfɛkt dɛm wae nɔr kin siriɔs, bɔt yu fɔ ripɔt to yu dɔktɔ if i nɔr de.
Alɛji we pɔsin kin gɛtSkin rash, it, swel na di fes, lip, tong ɔ trot, i nɔ izi fɔ blo.
Di sayn dɛn we de sho se pɔsin gɛt di sik Ay fiva, kol, trot we de at, wund we nɔ de wɛl, pen we yu de pis.
Di sayn dɛm wae de sho se yu at nɔr de woke fayn I nɔ izi fɔ blo, yu anklɛ, yu fut ɔ yu an kin swel, yu bɔdi kin gɛt bɔku bɔku wet wantɛm wantɛm, yu kin taya pasmak.
Sindrom we tan lɛk lupus Jɔyn pen ɔ swel, spat dɛn we tan lɛk bɔtaflay na yu fes, rash we kin wɔs we yu de na di san, fiva.
Blɔd ɔ brus Brus fɔ no rizin ɔ blɔd bɔku bikɔs ɔf smɔl injuri.
Di kwaliti dɛm fɔ di nervɔs sistɛm Yu kin swɛla, yu kin swɛt, yu kin si chenj, ɛn yu bɔdi kin wik.
Diziz we pɔsin kin gɛt Rɛd, it, ɔ pen na di say we dɛn injekt.
Fiva Trot we de at, nos we de rɔn, ɔ nos we de stɔp.

Aw fɔ kip di mɛrɛsin? (Fɔ di wan dɛn we de yuz na os)

If yu de yuz di vaysin na os, i rili impɔtant fɔ kip am kɔrɛkt wan.
  • Frij (di bɛst we): Stɔr am na di nɔmal pat na di frij (bitwin 2-8 digri sɛlshiɔs). Nɔ ɛva kip am na friza. Nɔ yuz di mɛrɛsin if i friz.
  • Fɔ kip am na rum tɛmpracha:If nid de, dɛn kin kip di mɛrɛsin na rum tɛmpracha (dɔwn 25 digri sɛlshiɔs) fɔ te 30 dez. Bɔt we dɛn dɔn pul di mɛrɛsin na frij, nɔ put am bak na frij. If yu nɔ yuz am insay 30 dez, pul am.
  • Ɔda pɔynt dɛn: Kip di mɛrɛsin insay di fɔs pak, fa frɔm layt. Nɔ shek di mɛrɛsin bɔtul ɔ sirinj bifo yu yuz am.
Aks yu dɔktɔ aw fɔ trowe di mɛrɛsin dɛn we dɔn pas ɔ we yu nɔ nid igen, sef wan.

Mɛsej we dɛn kin kɛr go na os

  • Golimumab na wan rili impɔtant ɛn pawaful mɛrɛsin fɔ ɔtoimyun sik dɛn. So, na ɔnda dɔktɔ advays nɔmɔ yu fɔ yuz am ɔltɛm.
  • Bifo yu bigin fɔ trit yu, tɛl yu dɔktɔ ɔl bɔt ɔl yu mɛrɛsin ɛn ɔl di ɔda mɛrɛsin dɛn we yu de tek.
  • Tek spɛshal kia fɔ protɛkt yusɛf frɔm infɛkshɔn we yu de tek dis mɛrɛsin. If yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, go to dɔktɔ wantɛm wantɛm.
  • Tek di doz we dɛn tɛl yu fɔ tek di tɛm we yu gi yu. If yu mis wan doz, nɔ panik ɛn go to yu dɔktɔ. Nɔ ɛva tek tu dos di sem tɛm.
  • If yu yuz di vaysin na os, trowe di nidul ɛn sirinj dɛn we yu dɔn yuz fayn fayn wan, na spɛshal kɔntena we gɛt shap nɔmɔ.
Golimumab, at at, ɔlsɛrativ kɔlayt, ɔtoimyun, TNF inhibito, vaksin, sayd ɛfɛkt
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 5 + 1 =
Golimumab vaysin: Ɔltin we yu nid fɔ no

Golimumab vaysin: Ɔltin we yu nid fɔ no

Yu gɛt siriɔs sik lɛk at at sik ɔr ɔlsa kɔlayt? Dɔn yu no aw i kin ambɔg yu ɛvride layf. Golimumab na spɛshal, mɔdan mɛrɛsin we dɔktɔ dɛn kin yuz fɔ kɔntrol dɛn sik ya. Lɛ wi tɔk bɔt am tide.

Wetin na Golimumab?

Fɔ tɔk am simpul wan, Golimumab na vaysin we de kɔntrol di wok we yu bɔdi in imyun sistɛm de du. Nɔmal wan, wi imyun sistɛm in wok na fɔ protɛkt wi bay we i de fɛt di jem dɛn we de mek wi gɛt sik. Bɔt sɔntɛnde, dis sistɛm kin wok pasmak ɛn mistek kin bigin fɔ atak wi yon gud sɛl dɛn. Wi kin kɔl dɛn kɔndishɔn ya ɔtoimyun kɔndishɔn. At at ɛn ɔlsa kɔlayt na tu kayn sik dɛn ya. Golimumab de wok bay we i de kɔl di ɔvaaktiv imyun sistɛm. fכ mεdikal, i de pan wan klas כf drog dεm we dεn kכl `TNF inhibitors`. Dat min se i de blok wan protin (TNF) na wi bɔdi fɔ sɔm tɛm we de mek wi fil pen ɛn swel. na wan kayn `monoclonal antibodi` bak. Dat min se na spɛshal prɔtin we dɛn mek na di lɛbɔraytri fɔ wok pan wan patikyula tin nɔmɔ we dɛn want fɔ du. Lɛk mishɔl we de nak di say we i want fɔ go.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu tek dis mɛrɛsin

Bikɔs dis na mɛrɛsin we rili pawaful, yu dɔktɔ nid fɔ gɛt kɔmplit pikchɔ bɔt yu wɛlbɔdi. So, if yu gɛt ɛni wan pan dɛn tin ya, tɛl yu dɔktɔ ɛn nɔ ayd ɛnitin .
Situeshɔn we yu nid fɔ ripɔt Wetin mek dat impɔtant?
Di sik dɛn we yu gɛt naw ɔ we yu jɔs gɛt (fiva, kɔf, kol) . Bikɔs golimumab de stɔp di imyun sistɛm, di infɛkshɔn kin bi mɔ bad.
Tuberculosis , ɔr kin gɛt tayt padi biznɛs wit pɔrsin wae gɛt TB.Dis mɛrɛsin kin mek di TB jem dɛm we de slip na di bɔdi wok bak.
Fɔ gɛt ɔ fɔ wɛl frɔm kansa . Di dɔktɔ fɔ no se dis mɛrɛsin kin gɛt fɔ du wit sɔm prɔblɛm dɛn we kin mek pɔsin gɛt kansa.
At sik dɛm lɛk at pwɛl hat . Sɔntɛnde, dis mɛrɛsin kin mek di at sik wɔs.
Shuga Di risk fɔ gɛt infɛkshɔn dɔn ɔlrɛdi bɔku bikɔs ɔf dayabitis, ɛn dis mɛrɛsin kin mek i bɔku mɔ.
Fɔ gɛt Epatitis B infɛkshɔn. Risk de fɔ mek di dormant hepatitis B vayrɔs aktiv bak bikɔs ɔf dis mɛrɛsin.
Sik dεm na di nεv sεstem (e.g. mכltipכl sklεrosis, Guillain-Barre syndrome). Sɔntɛm, dis mɛrɛsin kin afɛkt di nervɔs sistɛm.
We dɛn jɔs dɔn gɛt ɔ we dɛn dɔn sɛtul fɔ gɛt di vaysin . I nɔ fayn mɔ fɔ gɛt layf vaysin we yu de tek dis mɛrɛsin.
Tray fɔ gɛt bɛlɛ, fɔ gɛt bɛlɛ , ɔ fɔ gi pikin in bɛlɛ . Insay dɛn kayn tin ya, i rili impɔtant fɔ tɔk to yu dɔktɔ bɔt aw di mɛrɛsin go afɛkt yu.
Fɔ gɛt alɛji to ɔda mɛrɛsin, rɔba, lɛtɛks, ɛn ɔda tin dɛn. Dis impɔtant fɔ mek yu nɔ gɛt alɛji fɔ di mɛrɛsin ɔ di tin we dɛn pak am.

Aw yu kin yuz dis mɛrɛsin?

Dɛn kin gi am golimumab tu we dɛn. 1. Insay wan vein: Dɛn kin gi dis na ɔspitul ɔ klinik bay wɛlbɔdi biznɛs pɔsin tru wan salin sɔlvushɔn. 2. Ɔnda di skin: Sɔntɛnde dɛn kin mek dis vaysin so dat yu go gi am to yusɛf na os. If na so i bi, yu dɔktɔ ɔ nɔs go sho yu di rayt we fɔ du am.
Di tin we impɔtant pas ɔl: If yu na pɔsin we de gi di vaysin na os, nɔ ɛva trowe nidul ɛn sirinj we yu dɔn yuz na di dɔti. Dɛn fɔ put dɛn insay kɔntena we gɛt shap tin dɛn . If yu nɔ gɛt wan, aks yu dɔktɔ fɔ wan.
Dɔn bak, yu go gɛt wan spɛshal liflet (`MedGuide`) wit di ditel dɛn bɔt dis mɛrɛsin. Rid am gud gud wan ɛvri tɛm. I go ɛksplen bɔku tin bɔt di mɛrɛsin to yu.

Yu kin gi dis to smɔl pikin dɛn?

Yɛs, insay sɔm spɛshal kes dɛm, dɛn kin gi dis mɛrɛsin fɔ pikin dɛm we ol lɛk 2 ia. Bɔt na wan dɔktɔ we de mɛn pikin dɛn kin disayd fɔ du dat.

Wetin a fɔ du if a mis apɔntinmɛnt fɔ tek mɛrɛsin?

  • If dɛn de gi yu mɛrɛsin na ɔspitul: If yu nɔ ebul fɔ go di de we dɛn dɔn sɛtul fɔ go, kɔl di ɔspitul ɔ klinik wantɛm wantɛm ɛn mek dɛn no. Dɛn go gi yu ɔda de.
  • If yu de tek yu mɛrɛsin na os: If yu mis wan doz, tek am jɔs lɛk aw yu mɛmba. Bɔt if i dɔn lɛf smɔl fɔ lɛ yu tek di nɛks doz, skip di doz we yu mis ɛn tek di nɛks doz di tɛm we yu dɔn sɛtul. Nɔ ɛva tek dabl doz. If yu nɔ shɔ, kɔl yu dɔktɔ fɔ advays.

Wetin kin apin if yu tek bɔku mɛrɛsin?

If yu tink se yu dɔn tek bɔku mɛrɛsin, nɔ panik ɛn tek akshɔn wantɛm wantɛm.
Wantɛm wantɛm, kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital ɔ go na di Imejɛnsi Tritmɛnt Yunit (ETU) na di ɔspitul we de nia yu.

Us ɔda mɛrɛsin dɛn we yu nɔ fɔ yuz wit dis mɛrɛsin?

Golimumab na wan mɛrɛsin we de afɛkt di imyun sistɛm, so i kin denja fɔ tek am wit ɔda mɛrɛsin dɛn we de du di sem tin.
Nɔ tek dɛn mɛrɛsin ya wit golimumab:Abatasɛpt, Adalimumab, Anakinra, Sɛtɔlizumab, Ɛtanɛsɛpt, Infliksimab, Rilɔnasɛpt, Rituximab, Tosilizumab ɛn layf vayrɔs vaysin dɛn.
Apat frɔm dat, sɔm ɔda mɛrɛsin dɛn kin miks wit dis mɛrɛsin. Dis list nɔ kɔmplit. So, i impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, lɛk vaytamɛn dɛn, tradishɔnal mɛrɛsin dɛn, ɛn sɔpɔtmɛnt dɛn.

Wetin a fɔ tek tɛm we a de tek di mɛrɛsin?

  • Fɔ chɛk-ap ɔltɛm na di mɛrɛsin : Go na klinik dɛn di tɛm we yu dɔn sɛtul lɛk aw yu dɔktɔ tɛl yu ɛn chɛk yu kɔndishɔn.
  • TB Test: Dɛn go tɛst yu fɔ TB bifo yu bigin dis mɛrɛsin. If di tɛst sho se yu gɛt TB jem na yu bɔdi, yu go nid fɔ bigin ɛn dɔn di ful kɔs fɔ TB mɛrɛsin bifo yu bigin fɔ tek golimumab.
  • Protekshɔn frɔm infɛkshɔn : Dis mɛrɛsin de mek yu imyuniti smɔl, so yu kin sik mɔ. So, if yu gɛt sɔm sayn dɛm lɛk fiva, kol , kɔf, ɛn ɔda tin dɛm, nɔr de mɛn yusɛf ɛn tɛl yu dɔktɔ. Tray fɔ de fa frɔm pipul dɛn we sik.
  • Risk fɔ gɛt kansa : I kin rili smɔl pan di risk fɔ gɛt sɔm kayn kansa we yu de tek dis mɛrɛsin. Bifo yu panik, tɔk opin wan wit yu dɔktɔ bɔt dis ɛn ɔndastand yu yon risk.

Us sayd ɛfɛkt dɛn we a go gɛt?

Lɛk ɔl mɛrɛsin, golimumab kin mek yu gɛt sayd ɛfɛkt, pan ɔl we nɔto ɔlman kin gɛt am.
Siriɔs sayd ɛfɛkt dɛm wae yu fɔ ripɔt to yu dɔktɔ kwik kwik wan: Sid ɛfɛkt dɛm wae nɔr kin siriɔs, bɔt yu fɔ ripɔt to yu dɔktɔ if i nɔr de.
Alɛji we pɔsin kin gɛtSkin rash, it, swel na di fes, lip, tong ɔ trot, i nɔ izi fɔ blo.
Di sayn dɛn we de sho se pɔsin gɛt di sik Ay fiva, kol, trot we de at, wund we nɔ de wɛl, pen we yu de pis.
Di sayn dɛm wae de sho se yu at nɔr de woke fayn I nɔ izi fɔ blo, yu anklɛ, yu fut ɔ yu an kin swel, yu bɔdi kin gɛt bɔku bɔku wet wantɛm wantɛm, yu kin taya pasmak.
Sindrom we tan lɛk lupus Jɔyn pen ɔ swel, spat dɛn we tan lɛk bɔtaflay na yu fes, rash we kin wɔs we yu de na di san, fiva.
Blɔd ɔ brus Brus fɔ no rizin ɔ blɔd bɔku bikɔs ɔf smɔl injuri.
Di kwaliti dɛm fɔ di nervɔs sistɛm Yu kin swɛla, yu kin swɛt, yu kin si chenj, ɛn yu bɔdi kin wik.
Diziz we pɔsin kin gɛt Rɛd, it, ɔ pen na di say we dɛn injekt.
Fiva Trot we de at, nos we de rɔn, ɔ nos we de stɔp.

Aw fɔ kip di mɛrɛsin? (Fɔ di wan dɛn we de yuz na os)

If yu de yuz di vaysin na os, i rili impɔtant fɔ kip am kɔrɛkt wan.
  • Frij (di bɛst we): Stɔr am na di nɔmal pat na di frij (bitwin 2-8 digri sɛlshiɔs). Nɔ ɛva kip am na friza. Nɔ yuz di mɛrɛsin if i friz.
  • Fɔ kip am na rum tɛmpracha:If nid de, dɛn kin kip di mɛrɛsin na rum tɛmpracha (dɔwn 25 digri sɛlshiɔs) fɔ te 30 dez. Bɔt we dɛn dɔn pul di mɛrɛsin na frij, nɔ put am bak na frij. If yu nɔ yuz am insay 30 dez, pul am.
  • Ɔda pɔynt dɛn: Kip di mɛrɛsin insay di fɔs pak, fa frɔm layt. Nɔ shek di mɛrɛsin bɔtul ɔ sirinj bifo yu yuz am.
Aks yu dɔktɔ aw fɔ trowe di mɛrɛsin dɛn we dɔn pas ɔ we yu nɔ nid igen, sef wan.

Mɛsej we dɛn kin kɛr go na os

  • Golimumab na wan rili impɔtant ɛn pawaful mɛrɛsin fɔ ɔtoimyun sik dɛn. So, na ɔnda dɔktɔ advays nɔmɔ yu fɔ yuz am ɔltɛm.
  • Bifo yu bigin fɔ trit yu, tɛl yu dɔktɔ ɔl bɔt ɔl yu mɛrɛsin ɛn ɔl di ɔda mɛrɛsin dɛn we yu de tek.
  • Tek spɛshal kia fɔ protɛkt yusɛf frɔm infɛkshɔn we yu de tek dis mɛrɛsin. If yu gɛt sɔm sayn dɛn lɛk fiva ɛn kɔf, go to dɔktɔ wantɛm wantɛm.
  • Tek di doz we dɛn tɛl yu fɔ tek di tɛm we yu gi yu. If yu mis wan doz, nɔ panik ɛn go to yu dɔktɔ. Nɔ ɛva tek tu dos di sem tɛm.
  • If yu yuz di vaysin na os, trowe di nidul ɛn sirinj dɛn we yu dɔn yuz fayn fayn wan, na spɛshal kɔntena we gɛt shap nɔmɔ.
Golimumab, at at, ɔlsɛrativ kɔlayt, ɔtoimyun, TNF inhibito, vaksin, sayd ɛfɛkt
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 5 + 1 =